|
Anxiety
|
0.080 |
Biomarker
|
disease |
BEFREE |
VAs were not significantly associated with the progression of symptoms of depression (adjusted relative risk [aRR] = 1.29, 95% confidence interval [CI] = 0.94-1.77) and anxiety (aRR = 1.22, 95% CI = 0.86-1.72), or with change in average scores of PHQ-2 and GAD-2 over time, both before and after risk adjustment.
|
30482494 |
2019 |
|
Anxiety
|
0.080 |
Biomarker
|
disease |
BEFREE |
Based on the rigorous standard suggested by the Quality Assessment of Diagnostic Accuracy Studies-2, a total of 1,157 participants randomly recruited from the community completed the GAD-7, GAD-2, and other anxiety and depression measures in a counter-balanced order.
|
30936840 |
2019 |
|
Anxiety
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Parental depression and anxiety were screened with the Patient Health Questionnaire-2 (PHQ-2) and Generalized Anxiety Disorder Scale-2 (GAD-2).
|
31222745 |
2019 |
|
Anxiety
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
A random sample of 688 undergraduate university students (mean age = 20.64 ±1.88 years; 53% men) completed a survey composed of a) questions about socio-demographics, academics, lifestyle behaviors, personality type, and smartphone use-related variables; b) 26-item Smartphone Addiction Inventory (SPAI) Scale; and c) brief screeners of depression and anxiety (PHQ-2 and GAD-2), which constitute the two core DSM-IV items for major depressive disorder and generalized anxiety disorder, respectively.
|
28777828 |
2017 |
|
Anxiety
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
We evaluated the association of PC-related anxiety (MAX-PC) with sociodemographic characteristics, family history of PC, global health status/quality of life (EORTC QLQ-C30), depression and anxiety (PHQ-2; GAD-2), latest PSA level, time since radical prostatectomy, and current therapy.
|
28528448 |
2017 |
|
Anxiety
|
0.080 |
Biomarker
|
disease |
BEFREE |
The Generalized Anxiety Disorder Scales GAD-7 and GAD-2 are instruments for the assessment of anxiety.
|
28088111 |
2017 |
|
Anxiety
|
0.080 |
Biomarker
|
disease |
BEFREE |
FMR1 gene polymorphisms, dopaminergic (DAT, DRD, COMT), serotonin (5-HTTLPR, HTR1A, HTR2A), interleukins, MCR1, HCN (potassium channel), neurorregulinas, GABAergic (GABA, GAD, DBI) DBI, GABA (Gabra) receptors and GAD genes (GAD1, GAD2) appear to contribute to generate condition of depression or anxiety like.
|
25106036 |
2014 |
|
Anxiety
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
These results support earlier studies that suggest associations of polymorphisms within the GAD2 locus with anxiety and affective disorders.
|
19229853 |
2009 |